Related Experiment Videos
Testing for human papillomavirus: basic pathobiology of infection, methodologies, and implications for clinical use
1Department of Pathology, University of Connecticut Health Center, Farmington.
The Yale Journal of Biology and Medicine
|March 1, 1991
Summary
Human papillomavirus (HPV) is increasingly linked to genital tract neoplasias. Advances in HPV testing simplify detection but spark debate on optimal management strategies for HPV infections.
Area of Science:
- Molecular biology
- Oncology
- Gynecology
Background:
- Emerging molecular evidence implicates human papillomavirus (HPV) in the etiology of genital tract neoplasias.
- Technological advancements have led to simpler, more reliable, and cost-effective HPV detection methods.
- The clinical utility and management of HPV infections using new diagnostic tests are subjects of ongoing controversy.
Purpose of the Study:
- To review the latest evidence linking HPV to neoplasia.
- To describe current methodologies for detecting HPV in clinical samples.
- To discuss the controversies surrounding the clinical application of HPV tests.
Main Methods:
- Literature review of molecular biology studies.
- Analysis of current HPV detection technologies.
- Examination of clinical guidelines and expert opinions on HPV management.
Main Results:
- Significant molecular evidence supports HPV's role in genital neoplasias.
- Current HPV tests offer improved sensitivity and accessibility.
- Discrepancies exist in recommendations for HPV test utilization in clinical practice.
Conclusions:
- HPV is a key etiological factor in genital tract neoplasias.
- Accessible HPV testing facilitates diagnosis and management.
- Standardized guidelines are needed to address the controversies in HPV test utilization for optimal patient care.